Services and Capabilities
Pre-clinical Formulation
Development
  • Rapid Dose Evaluation
  • In Vitro and in Vivo Testing

Find Out More

Early Phase Clinical
Trials
  • First-in-Human (FIH) Studies
  • Phase I / II Clinical Trials
  • Adaptive Clinical Trials
  • Patient Acceptability and Taste Evaluation

Find Out More

Patient-centric Design and
Production
  • Personalised Dosage and Design
  • Patient-Friendly Formulations
  • Multi-Drug Combinations
  • On-Demand Medicine Production

Find Out More

Services and Capabilities

Pre-clinical Formulation
Development
Pre-clinical Formulation
Development
  • Rapid Dose Evaluation
  • In Vitro and in Vivo Testing

Find Out More

Early Phase Clinical
Trials
Early Phase Clinical
Trials
  • First-in-Human (FIH) Studies
  • Phase I / II Clinical Trials
  • Adaptive Clinical Trials
  • Patient Acceptability and Taste Evaluation

Find Out More

Patient-centric Design and
Production
Patient-centric Design and
Production
  • Personalised Dosage and Design
  • Patient-Friendly Formulations
  • Multi-Drug Combinations
  • On-Demand Medicine Production

Find Out More

Using our proprietary Printlets™ technology, we can create a range of personalised medicines, composed of specific dosages, shapes, sizes and release profiles.

Design
Develop
Dispense

We specialise in developing a wide range of 3D printing technologies for your drug development needs

Stereolithography
Selective Laser Sintering
Fused Deposition Modelling
Semi-solid Extrusion

Latest News

September 03, 2019 | Press Release

FabRx performs the first clinical study using personalised 3D printed dosage forms to treat children with a rare metabolic disease

August 16, 2019 | Featured

FabRx publish in ONDrug Delivery on Personalising Medicines using 3D Printing

July 03, 2019 | Uncategorised

FabRx publish on Direct Powder Extrusion: a novel single-step 3D printing method for printlets

We are happy to be collaborating with…

Schedule Your Consultation Today

Copyright © 2018 FabRx Ltd